Skip to main content
OpenTrials

Clinical trial condition

Breast Diseases

Explore clinical trials studying Breast Diseases. Study availability and eligibility vary by location and protocol.

10,456 public trials 1,998 recruiting studies
Refine in advanced search Browse all conditions

Breast Diseases trial results

Completed

A Study of Foretinib in Patients With Recurrent/Metastatic Breast Cancer

NCT01147484

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +4 more
Locations
  • Tom Baker Cancer Centre Calgary, Alberta, Canada
  • BCCA - Cancer Centre for the Southern Interior Kelowna, British Columbia, Canada
  • BCCA - Vancouver Cancer Centre Vancouver, British Columbia, Canada
  • QEII Health Sciences Centre Halifax, Nova Scotia, Canada
View Trial Details
Completed

Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene

NCT03602079

Conditions
Adenocarcinoma, Adnexal Diseases, Bile Duct Cancer, +129 more
Locations
  • Florida Cancer Specialists & Research Institute Sarasota, Florida, United States
  • Beth Israel Deaconess Medical Center Cancer Center Boston, Massachusetts, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • Clinical Research Alliance, Inc. Lake Success, New York, United States
View Trial Details
Completed

Nigerian Breast Cancer Risk-Reduction Study

NCT05834933

Conditions
Behavior, Breast Cancer, Breast Diseases, +11 more
Locations
  • Obafemi Awolowo University Teaching Hospital Complex (OAUTHC) Ile-Ife, Osun State, Nigeria
  • University College Hospital (UCH) Ibadan, Oyo State, Nigeria
  • Lagos State University Teaching Hospital (LASUTH) Lagos, Nigeria
  • Lagos University Teaching Hospital (LUTH) Lagos, Nigeria
View Trial Details
Completed

Pegfilgrastim and Darbepoetin Alfa in Support of Adjuvant Chemotherapy for Breast Cancer

NCT00146562

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +6 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Faulkner Hospital Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
View Trial Details

Related conditions